Preclinical Data Of Syd985 Support The Clinical Investigation Of This Novel Anti-Her2 Antibody-Drug Conjugate In Breast Cancer Patients With Low Levels Of Her2 Expression
CANCER RESEARCH(2015)
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要
CANCER RESEARCH(2015)